These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. One-Stage Cartilage Repair Using a Hyaluronic Acid-Based Scaffold With Activated Bone Marrow-Derived Mesenchymal Stem Cells Compared With Microfracture: Five-Year Follow-up. Gobbi A, Whyte GP. Am J Sports Med; 2016 Nov; 44(11):2846-2854. PubMed ID: 27474386 [Abstract] [Full Text] [Related]
3. One-step surgery with multipotent stem cells for the treatment of large full-thickness chondral defects of the knee. Gobbi A, Karnatzikos G, Sankineani SR. Am J Sports Med; 2014 Mar; 42(3):648-57. PubMed ID: 24458240 [Abstract] [Full Text] [Related]
7. Results 2 Years After Matrix-Associated Autologous Chondrocyte Transplantation Using the Novocart 3D Scaffold: An Analysis of Clinical and Radiological Data. Zak L, Albrecht C, Wondrasch B, Widhalm H, Vekszler G, Trattnig S, Marlovits S, Aldrian S. Am J Sports Med; 2014 Jul; 42(7):1618-27. PubMed ID: 24817007 [Abstract] [Full Text] [Related]
8. Good mid-term outcomes after adipose-derived culture-expanded mesenchymal stem cells implantation in knee focal cartilage defects. Kyriakidis T, Iosifidis M, Michalopoulos E, Melas I, Stavropoulos-Giokas C, Verdonk R. Knee Surg Sports Traumatol Arthrosc; 2020 Feb; 28(2):502-508. PubMed ID: 31493012 [Abstract] [Full Text] [Related]
15. A Biomimetic Osteochondral Scaffold Augmented With Filtered Bone Marrow Aspirate for the Treatment of Joint Surface Lesions in the Knee. Kolar M, Veber M, Girandon L, Drobnič M. Am J Sports Med; 2024 Jun; 52(7):1826-1833. PubMed ID: 38767159 [Abstract] [Full Text] [Related]
16. The Clinically Important Difference and Patient Acceptable Symptomatic State for Commonly Used Patient-Reported Outcomes After Knee Cartilage Repair. Chahal J, Lansdown DA, Davey A, Davis AM, Cole BJ. Am J Sports Med; 2021 Jan; 49(1):193-199. PubMed ID: 33226845 [Abstract] [Full Text] [Related]
17. Allogenic umbilical cord blood-derived mesenchymal stromal cell implantation was superior to bone marrow aspirate concentrate augmentation for cartilage regeneration despite similar clinical outcomes. Yang HY, Song EK, Kang SJ, Kwak WK, Kang JK, Seon JK. Knee Surg Sports Traumatol Arthrosc; 2022 Jan; 30(1):208-218. PubMed ID: 33492407 [Abstract] [Full Text] [Related]
18. Second-Look Arthroscopic Evaluation of Cartilage Lesions After Mesenchymal Stem Cell Implantation in Osteoarthritic Knees. Koh YG, Choi YJ, Kwon OR, Kim YS. Am J Sports Med; 2014 Jul; 42(7):1628-37. PubMed ID: 24743139 [Abstract] [Full Text] [Related]
19. Clinical and radiological long-term outcomes after matrix-induced autologous chondrocyte transplantation: a prospective follow-up at a minimum of 10 years. Aldrian S, Zak L, Wondrasch B, Albrecht C, Stelzeneder B, Binder H, Kovar F, Trattnig S, Marlovits S. Am J Sports Med; 2014 Nov; 42(11):2680-8. PubMed ID: 25204296 [Abstract] [Full Text] [Related]
20. Clinical and radiographic outcomes of chitosan-glycerol phosphate/blood implant are similar with hyaluronic acid-based cell-free scaffold in the treatment of focal osteochondral lesions of the knee joint. Sofu H, Camurcu Y, Ucpunar H, Ozcan S, Yurten H, Sahin V. Knee Surg Sports Traumatol Arthrosc; 2019 Mar; 27(3):773-781. PubMed ID: 30069652 [Abstract] [Full Text] [Related] Page: [Next] [New Search]